Literature DB >> 7826521

Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats.

G P Dohanich1, A J Fader, D J Javorsky.   

Abstract

The purpose of the experiments was to determine if steroid hormone treatments would attenuate the effect of the muscarinic receptor blocker scopolamine on a memory task. Ovariectomized rats were trained first to alternate for food reward between the arms of a T maze. Following training, females treated with scopolamine hydrobromide (0.2 mg/kg ip) did not alternate correctly between the arms of the T maze and responded at chance levels. However, when estradiol benzoate (25 micrograms) was administered 72, 48, and 24 hr before testing alone or in combination with progesterone (500 micrograms) administered 4-6 hr before testing, females alternated successfully between the arms of the T maze following scopolamine administration. Results indicate that gonadal steroids can completely counteract the impairment of T maze performance induced by scopolamine in female rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826521     DOI: 10.1037//0735-7044.108.5.988

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  24 in total

1.  Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats.

Authors:  Joshua S Talboom; Brice J Williams; Edmond R Baxley; Stephen G West; Heather A Bimonte-Nelson
Journal:  Neurobiol Learn Mem       Date:  2008-05-16       Impact factor: 2.877

2.  Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys.

Authors:  M L Voytko; C J Higgs; R Murray
Journal:  Neuroscience       Date:  2008-05-03       Impact factor: 3.590

Review 3.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

Review 4.  The Role of Estrogen in Brain and Cognitive Aging.

Authors:  Jason K Russell; Carrie K Jones; Paul A Newhouse
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 5.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

6.  An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

Authors:  J I Acosta; R Hiroi; B W Camp; J S Talboom; H A Bimonte-Nelson
Journal:  Brain Res       Date:  2013-01-16       Impact factor: 3.252

Review 7.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

Review 8.  The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review.

Authors:  Ioannis Bakoyiannis; Eleousa-Alexandra Tsigka; Despina Perrea; Vasilios Pergialiotis
Journal:  Clin Drug Investig       Date:  2016-02       Impact factor: 2.859

Review 9.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Effects of two years of conjugated equine estrogens on cholinergic neurons in young and middle-aged ovariectomized monkeys.

Authors:  Carole Browne; Joseph R Tobin; Mary Lou Voytko
Journal:  Brain Res       Date:  2009-01-20       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.